Articles Tagged With: ards
-
In the Setting of Non-COVID ARDS, Improvement in Oxygenation with Proning Predicts Survival
In this retrospective cohort study, improvement in the PaO2/FiO2 (P/F) ratio by 54% was the optimal cutoff to predict those more likely to be alive at 28 days.
-
Prone Positioning in Acute Respiratory Distress Syndrome
A review of the potential benefits and uses of prone positioning in patients with acute respiratory distress syndrome
-
Mechanical Ventilation for Pneumonia, Acute Respiratory Distress Syndrome, and COVID-19
This article discusses mechanical ventilation for patients with pneumonia, acute respiratory distress syndrome, and COVID-19.
-
COVID-19 and Steroids: Is There a Consensus?
A study of adults admitted with COVID-19 pneumonia revealed risk factors associated with developing acute respiratory distress syndrome (ARDS) and progression from ARDS to death included older age, neutrophilia, organ dysfunction, and coagulation derangement.
-
Managing COVID-19 Respiratory Failure: Is There a Perfect Management Strategy?
COVID-19 is a systemic disease that primarily injures the vascular endothelium, causing a unique lung injury in which different management strategies may need to be considered to address the specific physiology of each patient.
-
Maximal Lung Recruitment Strategy Does Not Reduce Ventilator-Free Days in the Setting of Acute Respiratory Distress Syndrome
In this randomized trial, daily maximal recruitment trials failed to reduce ventilator-free days in the setting of acute respiratory distress syndrome, but increased the risk of cardiovascular adverse effects.
-
Early Neuromuscular Blockade in Moderate-to-Severe Acute Respiratory Distress Syndrome
When the early use of a continuous infusion of cisatracurium was compared to contemporary supportive care for moderate-to-severe ARDS, including a light sedation target, high positive-end expiratory pressure, and conservative fluid strategy, there was no difference in 90-day mortality. Patients in the early neuromuscular blockade group more frequently experienced a severe cardiovascular event and ICU-acquired weakness by day 28.